EVIDENCE LIBRARY
Benzodiazepine Discontinuation Review Shows Why CBT Success Rates Need Study-Level Context
A review supports behavioral treatment during benzodiazepine discontinuation, but its individual trials do not all show the same additional benefit. Broad success percentages should be tied to the population and follow-up that produced them.
A review supports behavioral treatment during benzodiazepine discontinuation, but its individual trials do not all show the same additional benefit. Broad success percentages should be tied to the population and follow-up that produced them.
Treating the condition as well as reducing medication
Chapoutot and colleagues reviewed cognitive behavioral therapy and acceptance and commitment therapy for long-term benzodiazepine use in insomnia and anxiety disorders. Their framework addresses both medication use and the underlying symptoms that make reduction difficult.
The review describes techniques for managing worry, panic, insomnia, and responses to withdrawal sensations. This is clinically different from treating discontinuation as a simple instruction to stop a medication.
The trial table is more informative than a single headline rate
Although the abstract describes substantial abstinence success with CBT, the review’s table includes varied results. A small panic-disorder trial reported better maintenance of discontinuation at six months with CBT, despite no significant early difference. Another trial reported no additional benefit from its group CBT component over tapering alone at the reported three-month assessment.
These differences do not negate behavioral treatment. They show that diagnosis, intervention format, comparison treatment, sample size, and follow-up all affect the question being answered. Acceptance and commitment therapy is also discussed through its theoretical rationale and developing evidence base; it should not automatically inherit the evidence strength of every traditional CBT trial.
Using the review accurately
For an expert opinion, specify whether success means stopping at treatment completion, remaining medication-free later, or reducing use. Do not convert a selected percentage into a guaranteed outcome for an individual.
The article is a literature review, not a new head-to-head trial establishing one universal withdrawal approach. Its strongest practical contribution is the need to address persistent insomnia or anxiety alongside supervised medication change, while recognizing variation in the underlying studies.
Source
Based on the supplied paper: Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for the Discontinuation of Long T. PMC8508349.